What is WAL's health score?

WESTERN ALLIANCE BANCORPORATION (WAL) has a TradeApes health score of 52 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is WAL's estimated fair value?

Based on our 5-year discounted cash flow model, WESTERN ALLIANCE BANCORPORATION's estimated fair value is $96.28 per share, representing a 20.9% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is WAL undervalued or overvalued?

Our model currently rates WAL as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for WAL... Refresh in a moment for the full analysis.

WESTERN ALLIANCE BANCORPORATION (WAL)

Financials Undervalued medium mixed

$79.65

Updated: 2026-05-30

TradeApes Score

Financial Strength

40 Weak

Operating Trend

75 Strong

Relative Value

50 Mixed

Capital Allocation

20 Stressed

Risk

80 Strong

Est. Fair Value $96.28

DCF Upside +20.9%

Sector Rank #4345 of 6433

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.